Literature DB >> 23419431

Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic hematopoietic SCT.

E Palfreyman, K Song, S Nantel.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23419431     DOI： 10.1038/bmt.2013.12

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression.

Authors:  Polona Novak; Evgeny Klyuchnikov; Ute-Marie von Pein; Martina Güllstorf; Maximilian Christopeit; Francis Ayuk; Maria Geffken; Christine Wolschke; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2020-04-29       Impact factor: 5.483

2.  Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation.

Authors:  Masaharu Tamaki; Hidenori Wada; Ayumi Gomyo; Jin Hayakawa; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Yuko Ishihara; Koji Kawamura; Aki Tanihara; Miki Sato; Kiriko Terasako-Saito; Kazuaki Kameda; Misato Kikuchi; Shun-Ichi Kimura; Hideki Nakasone; Shinichi Kako; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-07-06       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.